Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCK-PD: Fasudil for Parkinson's Disease
2024-517413-33-00Phase 2Completed
- Sponsor
- Klinikum rechts der Isar
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fasudil in Parkinson's disease (PD) (3 arms), sponsored by Klinikum rechts der Isar. Primary endpoint: Combined safety endpoint. Started Jun 2023; status: completed.
02
Drugs
fasudil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2024-517413-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517413-33-00.